Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › P53-targeting vaccines and pd-1 pathway inhibitors and methods of use thereof

P53-targeting vaccines and pd-1 pathway inhibitors and methods of use thereof

US Patent 11602554 · Granted Mar 14, 2023

Estimated economic value: $3,980,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of triplex CMV vaccine in CAR T cell therapy2025
Genetically stable recombinant modified vaccinia Ankara (RMVA) vaccines and meth2025
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
MVA vaccine for delivery of a UL128 complex and preventing CMV infection2024
Genetically modified recombinant vaccinia ankara (RMVA) vaccines of improved sta2024
Expression system for expressing herpesvirus glycoprotein complexes2023
MVA vaccine for delivery of a UL128 complex and preventing CMV infection2023
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2023
Genetically stable recombinant modified vaccinia Ankara (rMVA) vaccines and meth2023
Expression system for expressing herpesvirus glycoprotein complexes2022
MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infec2022
Anticancer combinations2021